MENU
ORGO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Organogenesis Holdings (ORGO) Ownership - Who owns Organogenesis Holdings?

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets... Show more

Profile

Industry
Financial Conglomerates
Address
85 Dan Road
Phone
+1 781 575-0775
Employees
862
Web
https://www.organogenesis.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
374.78M
P/E Ratio
70.25
Total Cash
103.84M
Projected Growth
N/A
Total Debt
119.35M
Revenue
433.14M
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash/Share
0.79
Total Debt/Equity
N/A
Revenue/Share
3.26 USD as % of share price

Fundamentals

ORGO
Capitalization
375M
P/E Ratio
70.25
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash
104M
Total Cash/Share
0.79
Total Debt
119M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.26%
Revenue
433M
ROE
N/A
Book Value
279M
P/B Ratio
1.33
Cash Flow
N/A
Earnings
0.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
2.80
Current Revenue Per Employee
115604.41
Dividends Per Share - Security
N/A
EBITDA
36M
Float
N/A
Float - Current
N/A
Gross Income Margin
72.13
Revenue To Assets
1.09
Shares Held By Institutions
300M
Shares Outstanding - Current
132M
Total Liabilities
181M
Total Volume MTD
N/A
Value
-1
Gain YTD
33.750
View a ticker or compare two or three
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Financial Conglomerates
Address
85 Dan Road
Phone
+1 781 575-0775
Employees
862
Web
https://www.organogenesis.com